However, the increasing list of tumor types, including AML[19,20], glioblastoma[21], hepatocellular carcinoma[22], melanoma[23], ovarian cancer[12], cervical cancer[24] and others[25-27], showing high DEK protein expression raises the exciting possibility of using DEK as a tumor marker[6]. This evidence concerns the gene DEK and acute myeloid leukemia.